EFFECTOR Therapeutics Q4 EPS $(3.42) Misses $(1.65) Estimate
EFFECTOR Therapeutics Q4 EPS $(3.42) Misses $(1.65) Estimate
EFFECTOR Therapeutics第四季度每股收益美元（3.42美元）未达到预期（1.65美元）
eFFECTOR Therapeutics (NASDAQ:EFTR) reported quarterly losses of $(3.42) per share which missed the analyst consensus estimate of $(1.65) by 107.27 percent. This is a 37.82 percent increase over losses of $(5.50) per share from the same period last year.
Effector Therapeutics（纳斯达克股票代码：EFTR）公布的季度亏损为每股3.42美元（3.42美元），比分析师普遍预期的1.65美元（1.65美元）低107.27％。这比去年同期每股亏损5.50美元（5.50）增长了37.82％。